Page last updated: 2024-09-03

bw 373u86 and Morphine Abuse

bw 373u86 has been researched along with Morphine Abuse in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, KJ; Lee, PH; McNutt, RW	1

Other Studies

1 other study(ies) available for bw 373u86 and Morphine Abuse

Article	Year
A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:2 Topics: Animals; Benzamides; Injections, Subcutaneous; Male; Morphine; Morphine Dependence; Naloxone; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Substance Withdrawal Syndrome; Time Factors	1993

Article

Year

A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.

The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:2

Topics: Animals; Benzamides; Injections, Subcutaneous; Male; Morphine; Morphine Dependence; Naloxone; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Substance Withdrawal Syndrome; Time Factors

1993